Erratum: Inhibition of SREBP by a Small Molecule, Betulin, Improves Hyperlipidemia and Insulin Resistance and Reduces Atherosclerotic Plaques (Inhibition of SREBP by a Small Molecule, Betulin, Improves Hyperlipidemia and Insulin Resistance and Reduces Atherosclerotic Plaques (2011) 13(1) (44–56), (S1550413110004468), (10.1016/j.cmet.2010.12.004))

  • Jing Jie Tang
  • , Jia Gui Li
  • , Wei Qi
  • , Wen Wei Qiu
  • , Pei Shan Li
  • , Bo Liang Li
  • , Bao Liang Song*
  • *Corresponding author for this work

Research output: Contribution to journalComment/debate

8 Scopus citations

Abstract

(Cell Metabolism 13, 44–56; January 5, 2011) In the originally published version of this article, an incorrect chart was mistakenly used in Figure S3A. The data were replaced when we copied the formula from another dataset for calculation. This error does not affect the conclusions of the paper. The authors apologize for any confusion that this error may have caused.

Original languageEnglish
Pages (from-to)222
Number of pages1
JournalCell Metabolism
Volume33
Issue number1
DOIs
StatePublished - 5 Jan 2021

Fingerprint

Dive into the research topics of 'Erratum: Inhibition of SREBP by a Small Molecule, Betulin, Improves Hyperlipidemia and Insulin Resistance and Reduces Atherosclerotic Plaques (Inhibition of SREBP by a Small Molecule, Betulin, Improves Hyperlipidemia and Insulin Resistance and Reduces Atherosclerotic Plaques (2011) 13(1) (44–56), (S1550413110004468), (10.1016/j.cmet.2010.12.004))'. Together they form a unique fingerprint.

Cite this